[go: up one dir, main page]

WO1998015535B1 - 1,4-benzodiazepinones et leurs utilisations en tant qu'antagonistes de cck - Google Patents

1,4-benzodiazepinones et leurs utilisations en tant qu'antagonistes de cck

Info

Publication number
WO1998015535B1
WO1998015535B1 PCT/JP1997/003483 JP9703483W WO9815535B1 WO 1998015535 B1 WO1998015535 B1 WO 1998015535B1 JP 9703483 W JP9703483 W JP 9703483W WO 9815535 B1 WO9815535 B1 WO 9815535B1
Authority
WO
WIPO (PCT)
Prior art keywords
compound
formula
cycloalkyl
benzodiazepinones
pharmaceutically acceptable
Prior art date
Application number
PCT/JP1997/003483
Other languages
English (en)
Other versions
WO1998015535A1 (fr
Filing date
Publication date
Priority claimed from AUPO2843A external-priority patent/AUPO284396A0/en
Application filed filed Critical
Priority to EP97941281A priority Critical patent/EP0934282A1/fr
Priority to US09/269,752 priority patent/US6291452B1/en
Priority to JP51737298A priority patent/JP2001504454A/ja
Publication of WO1998015535A1 publication Critical patent/WO1998015535A1/fr
Publication of WO1998015535B1 publication Critical patent/WO1998015535B1/fr

Links

Abstract

L'invention concerne des dérivés de benzodiazépine de formule (I), qui sont utiles en tant qu'antogonistes de la cholécystokinine. Dans la formule (I), R2 représente alkyle ou cycloalkyle-alkyle lorsque R4 représente hydrogène, ou R2 représente divers groupes spécifiés lorsque R4 représente alkyle, halogène ou dialkylamino.
PCT/JP1997/003483 1996-10-08 1997-09-29 1,4-benzodiazepinones et leurs utilisations en tant qu'antagonistes de cck WO1998015535A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP97941281A EP0934282A1 (fr) 1996-10-08 1997-09-29 1,4-benzodiazepinones et leurs utilisations en tant qu'antagonistes de cck
US09/269,752 US6291452B1 (en) 1996-10-08 1997-09-29 1,4-benzodiazepinones and their uses as CCK antagonists
JP51737298A JP2001504454A (ja) 1996-10-08 1997-09-29 ベンゾジアゼピン誘導体

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPO2843 1996-10-08
AUPO2843A AUPO284396A0 (en) 1996-10-08 1996-10-08 Benzodiazepine derivatives

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US09/269,752 A-371-Of-International US6291452B1 (en) 1996-10-08 1997-09-29 1,4-benzodiazepinones and their uses as CCK antagonists
US09/897,888 Continuation US20020002163A1 (en) 1996-10-08 2001-07-05 1,4-benzodiazepinones and their uses as CCK antagonists

Publications (2)

Publication Number Publication Date
WO1998015535A1 WO1998015535A1 (fr) 1998-04-16
WO1998015535B1 true WO1998015535B1 (fr) 1998-06-11

Family

ID=3797154

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP1997/003483 WO1998015535A1 (fr) 1996-10-08 1997-09-29 1,4-benzodiazepinones et leurs utilisations en tant qu'antagonistes de cck

Country Status (5)

Country Link
US (3) US6291452B1 (fr)
EP (1) EP0934282A1 (fr)
JP (1) JP2001504454A (fr)
AU (1) AUPO284396A0 (fr)
WO (1) WO1998015535A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1384867A (zh) 1999-08-27 2002-12-11 宝洁公司 稳定性提高的配制组分、使用该组分的组合物和洗衣方法
DE60028387T2 (de) * 1999-08-27 2007-05-24 The Procter & Gamble Company, Cincinnati Bleichverstärkende verbindungen, zusammensetzungen und waschverfahren
US6818607B1 (en) 1999-08-27 2004-11-16 Procter & Gamble Company Bleach boosting components, compositions and laundry methods
US6903060B1 (en) 1999-08-27 2005-06-07 Procter & Gamble Company Stable formulation components, compositions and laundry methods employing same
US7109156B1 (en) 1999-08-27 2006-09-19 Procter & Gamble Company Controlled availability of formulation components, compositions and laundry methods employing same
US6825160B1 (en) 1999-08-27 2004-11-30 Procter & Gamble Company Color safe laundry methods employing cationic formulation components
US6821935B1 (en) 1999-08-27 2004-11-23 Procter & Gamble Company Color safe laundry methods employing zwitterionic formulation components
US7169744B2 (en) 2002-06-06 2007-01-30 Procter & Gamble Company Organic catalyst with enhanced solubility
US7557076B2 (en) 2002-06-06 2009-07-07 The Procter & Gamble Company Organic catalyst with enhanced enzyme compatibility
AU2004229518B2 (en) * 2003-04-15 2010-02-18 Merck Sharp & Dohme Corp. CGRP receptor antagonists
US7196079B2 (en) * 2003-06-26 2007-03-27 Merck & Co, Inc. Benzodiazepine CGRP receptor antagonists
WO2005013894A2 (fr) * 2003-06-26 2005-02-17 Merck & Co., Inc. Antagonistes du recepteur du cgrp de
DE10352067A1 (de) * 2003-10-23 2005-05-25 Bayer Cropscience Ag Isopentylcarboxanilide
AU2004285636A1 (en) * 2003-10-23 2005-05-12 Bayer Cropscience Aktiengesellschaft Isopentyl carboxanilides for combating undesired micro-organisms
EP1765805B1 (fr) * 2004-01-29 2013-11-20 Merck Sharp & Dohme Corp. Antagonistes des recepteurs du cgrp
AR051659A1 (es) 2005-06-17 2007-01-31 Procter & Gamble Una composicion que comprende un catalizador organico con compatibilidada enzimatica mejorada
GB201414116D0 (en) 2014-08-08 2014-09-24 Trio Medicines Ltd Benzodiazepine derivatives
GB201513979D0 (en) 2015-08-07 2015-09-23 Trio Medicines Ltd Synthesis of benzodiazepine derivatives
CN113816914B (zh) * 2021-09-28 2024-04-09 华中药业股份有限公司 一种劳拉西泮中间体的制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820834A (en) * 1984-06-26 1989-04-11 Merck & Co., Inc. Benzodiazepine analogs
US4970207A (en) 1988-07-07 1990-11-13 Fujisawa Pharmaceutical Company, Ltd. Benzodiazepine derivatives
US5264433A (en) 1988-07-07 1993-11-23 Fujisawa Pharmaceutical Co., Ltd. Benzodiazepine derivatives
US5248679A (en) 1988-09-09 1993-09-28 Fujisawa Pharmaceutical Co., Ltd. Tricyclic compounds
IL91361A (en) 1988-09-09 1994-10-07 Fujisawa Pharmaceutical Co Disubstituted 1,9-annelated [1,4] benzodiazepinone compounds, processes for the preparation thereof and pharmaceutical compositions containing the same
IL96613A0 (en) * 1989-12-18 1991-09-16 Merck & Co Inc Pharmaceutical compositions containing benzodiazepine analogs
GB9018601D0 (en) 1990-08-24 1990-10-10 Fujisawa Pharmaceutical Co Tricyclic compounds
CA2068355A1 (fr) * 1991-05-14 1992-11-15 Mark S. Chambers Derives de benzodiazepines, compositions les contenant et leur utilisation therapeutique
DE69204040T2 (de) * 1991-12-20 1996-03-28 Merck Sharp & Dohme 3-Phenylureido-1,4-Benzodiazepinone und ihre Verwendung als Cholecystokinin- oder Gastrinantagonisten.
GB9203790D0 (en) * 1992-02-21 1992-04-08 Merck Sharp & Dohme Therapeutic agents
IL104853A (en) * 1992-02-27 1997-11-20 Yamanouchi Pharma Co Ltd Benzodiazepine derivatives, their preparation and pharmaceutical compositions containing them
EP0637308A1 (fr) * 1992-03-16 1995-02-08 MERCK SHARP & DOHME LTD. Derives de benzodiazepines, compositions les contenant et leur utilisation therapeutique
CA2130196A1 (fr) * 1992-03-24 1993-09-30 Jose Luis Castro Pineiro Derives de la benzodiazepine
US5360802A (en) * 1992-05-11 1994-11-01 Merck Sharpe & Dohme Ltd. Benzodiazepine derivatives, compositions containing them and their use in therapy
GB9225492D0 (en) * 1992-12-05 1993-01-27 Glaxo Group Ltd Amine derivatives
JPH09511998A (ja) * 1994-04-15 1997-12-02 グラクソ、ウェルカム、インコーポレーテッド 1,4 − ベンゾジアゼピン化合物を用いたコレシストキニンアゴニスト活性の誘導方法
CA2196062A1 (fr) 1994-07-29 1996-02-15 Yoshinari Sato Derives de benzodiazepine
US5556969A (en) * 1994-12-07 1996-09-17 Merck Sharp & Dohme Ltd. Benzodiazepine derivatives
US5929071A (en) * 1996-07-02 1999-07-27 Merck & Co., Inc. Method for the treatment of preterm labor

Similar Documents

Publication Publication Date Title
WO1998015535B1 (fr) 1,4-benzodiazepinones et leurs utilisations en tant qu'antagonistes de cck
CA2263913A1 (fr) Derives 6,6-hetero-bicycliques substitues
AU4064597A (en) Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof
IL124537A0 (en) Naphthyl-substituted benzimidazole derivatives and pharmaceutical compositions containing the same
CA2262692A1 (fr) Derives 6,6- ou 6,7-bicycliques contenant pyrido ou pyrimido substitues
CA2165819A1 (fr) Derives de dc-89
KR920002596A (ko) 아지비사이클로 유도체
AU2420897A (en) Meta-substituted phenylene sulphonamide derivatives
CA2128955A1 (fr) Benzazepines tricycliques antagonistes de la vasopressine
AU2337197A (en) Cinnamic acid derivatives and their use as integrin antagonists
WO2000027846A3 (fr) Antagonistes de recepteurs du crf et methodes associees
CA2237189A1 (fr) 3-azetidinylalkylpiperidines ou -pyrrolidines en tant qu'antagonistes des tachykinines
MY117092A (en) Chemotherapeutic pyrrolocarbazole derivatives
AU3215795A (en) Indole alkaloids useful as uv protective and anti-inflammatory agents
CA2260060A1 (fr) Derives de la distamycine acryloyl-substitues, procede de fabrication associe et leur utilisation comme agents antitumoraux et antiviraux
CA2383351A1 (fr) Derives de xanthine en tant qu'antagonistes selectifs des recepteurs a2b de l'adenosine
CA2204204A1 (fr) Derives de glucides
CA2300289A1 (fr) Composition pharmaceutique active dans la reduction de production de proteine mcp-1
AU4889496A (en) Pyrrolocarbazole derivatives
TW252979B (fr)
AU617188B2 (en) Azepines
WO1994017075B1 (fr) Derives de diazepine et compositions antivirales
EA199900684A1 (ru) Производные иминоазаантрациклинона для лечения амилоидоза
EP0370712A3 (fr) Dérivés de l'éthylamine et médicaments hypotenseurs les contenant
WO1997004783A3 (fr) Alcaloides de bis-1 oxaquinolizidine provenant d'une eponge marine et presentant une activite antitumorale